Skip to content
Sickle Cell Association of the National Capital Area, Inc.

Sickle Cell Association of the National Capital Area, Inc.

SCANCA, Inc.

  • HOME
  • LEARN
    • About Sickle Cell
    • Types of Sickle Cell Disease
    • Sickle Cell Trait
    • Complications of Sickle Cell Disease
    • Treatment
    • Promising Treatment Developments
  • CARE
    • Infants & Children
    • Adolescents
    • Women
    • Men
    • Adults
    • Families and Friends
  • Research
  • SUPPORT
    • Outreach
    • Research
    • Scholarship
    • Summer Camp
    • SCANCA Newsletter
  • Membership
    • 1 Year Membership Dues
    • 1 Year Organizations / Corporations Membership Dues
    • Scholarship Donation
  • Donate Now
  • ABOUT US

Author: ESB Technology

Refresh Yourself About Sickle Cell

February 5, 2017 ESB Technology News

Many individuals with sickle cell disease can live for long periods without experiencing severe symptoms of the disease. Awareness and[…]

Read more

Video: New Treatment for Sickle Cell Brings Hope and a Cure to Chicago Area Patients

February 2, 2017 ESB Technology Video

  Source Newsroom: University of Illinois at Chicago Newswise — Two brothers have been cured of their sickle cell disease[…]

Read more

First Patient in Phase 3 Hope Study in Sickle Cell

February 1, 2017 ESB Technology News

Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease SOUTH SAN Francisco,[…]

Read more

Video: Sickle Cell Anemia: A Patient’s Journey

February 1, 2017 ESB Technology Video

As a young child, Alexandria, now age 17, endured near-constant feelings of exhaustion and general sickness, which turned into severe[…]

Read more

Posts navigation

«Previous Posts 1 … 3 4 5

Virtual Sickle Cell Support Group

Sickle Cell Association of the National Capital Area, INC.
P.O. Box 41479
Washington, DC 20018-08792
(202) 271-5733
email@scancainc.org
Copyright 2017